Capvizr

Teladoc Raises $900 million Growth Round

Company profile · Healthcare & Life Sciences · Updated February 1, 2022

Teladoc raised $900M in Growth Round financing led by Various. AI-powered telehealth platform at global scale. The new capital is framed around Build AI chronic disease management and expand to international markets.

Growth Round$900 millionTotal tracked $900 millionPurchase, NY

What it does

AI-powered telehealth platform at global scale. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.

Traction

76M+ members; AI triage routes to appropriate care level with 95% accuracy. Management framed the new capital around Build AI chronic disease management and expand to international markets.

Trend impact

Telehealth at scale competing with CVS Health for virtual care dominance. The capital raise matters because it gives the company more room to compete for customers, talent, and mindshare while incumbents and adjacent startups respond with clearer product depth or distribution.

Funding history

  • February 1, 2022 · Growth Round · $900 million · Various

Products & services

  • Healthcare & Life Sciences workflow monitoring tied to the funding announcement
  • Customer-facing product described on the company website
  • Operational tooling for healthcare & life sciences teams
  • Data capture and reporting across core business processes
  • Team expansion support funded by the latest round
Open Teladoc in the interactive Capvizr dashboard →